Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
General Dermatology
What is your late or no-show policy for patients?
Related Questions
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?
Have you encountered idiopathic aseptic facial granuloma in areas other than the face?
How would you approach treatment failures with squamous cell carcinoma-keratoacanthoma-type lesions that did not respond to a standard SRT regimen after many sessions?
How would you manage a patient with nonspecific clinical symptoms and pathology consistent with spongiotic and psoriasiform dermatitis other than oral JAK inhibitors?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
What is the role of combination antimicrobial, antiviral, and immunomodulatory therapies in managing recurrent erythema multiforme with suspected infectious triggers?
What treatment would you offer a patient with extensive lymphangioma circumscriptum intermittently covering the entire abdomen?
How do you determine if a pyoderma gangrenosum lesion is “burned out"?
What work up do you pursue for splinter hemorrhages in an otherwise healthy patient?
What concentration of TCA is typically used to treat porokeratosis on the arms and legs?
